Leonteq Securities AG’s Moderna MRNA Stock Holding History

Leonteq Securities AG’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-6,000	Closed	-$249K	–	1309
2024 Q4	$249K	Hold	6,000	–	–	0.02%	493
2024 Q3	$401K	Hold	6,000	–	–	0.03%	352
2024 Q2	$713K	Sell	6,000 -12,800	-68%	-$1.62M	0.05%	253
2024 Q1	$2M	Sell	18,800 -111,900	-86%	-$11.3M	0.15%	154
2023 Q4	$13M	Buy	130,700 +44,800	+52%	+$3.77M	0.74%	31
2023 Q3	$8.87M	Buy	85,900 +50,000	+139%	+$5.58M	0.49%	49
2023 Q2	$4.36M	Sell	35,900 -82,600	-70%	-$11M	0.23%	109
2023 Q1	$18.2M	Buy	118,500 +46,000	+63%	+$7.59M	0.83%	22
2022 Q4	$13M	Hold	72,500	–	–	0.48%	35
2022 Q3	$8.57M	Hold	72,500	–	–	0.33%	60
2022 Q2	$10.4M	Sell	72,500 -27,500	-28%	-$3.93M	0.39%	50
2022 Q1	$17.2M	Buy	+100,000	New	+$16.8M	0.61%	34

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Leonteq Securities AG's MRNA Position: Q1 2026 in Review

Leonteq Securities AG reduced its Moderna (MRNA) stake by 9.9% in Q1 2026, selling an estimated $1.55M and leaving 302,375 shares worth $15.4M. The position accounts for 0.57% of the portfolio, ranked #33.

Leonteq Securities AG first reported a position in MRNA in Q4 2020 and has held it in 22 quarters since. The position peaked at $43.1M in Q2 2022. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

Leonteq Securities AG held 302,375 shares of Moderna worth $15.4M as of Q1 2026.
Leonteq Securities AG sold 33,291 Moderna shares in Q1 2026, an estimated $1.55M.
Moderna made up 0.57% of Leonteq Securities AG's portfolio in Q1 2026, its #33 holding.
Leonteq Securities AG first reported a position in Moderna in Q4 2020 and has held it in 22 quarters since.
Leonteq Securities AG's Moderna position peaked at $43.1M in Q2 2022.
722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Leonteq Securities AG's 13F filing for Q1 2026, filed 27 Apr 2026.